The fear for shareholders is that a delay could mean that mRNA-1345 won’t be ready to roll out in the US in time for the ...
The FDA is working to conclude its review by the end of May 2024. The Food and Drug Administration (FDA) has informed Moderna that its review of the Biologics License Application (BLA) for mRNA-1345, ...
Moderna stock skidded Friday after the FDA delayed an approval decision on its RSV vaccine until the end of the month.
The FDA hasn't informed Moderna of any issues related to vaccine safety, efficacy or quality that would prevent approval, ...
By Colin Kellaher Moderna on Friday said the Food and Drug Administration won't meet its May 12 target action date for a decision on the company's ...
Moderna Chief Executive Officer Stéphane Bancel talks about how the biotech giant is cutting costs and developing new vaccines. The drugmaker expects to have its vaccine for respiratory syncytial ...
First, a bit of background on Moderna's RSV candidate. RSV generally causes cold-like symptoms, but the virus could be severe ...
PLEZi Nutrition, the Public Benefit Company co-founded by former First Lady Michelle Obama, today announced its official ...
The S&P 500 finished flat on Monday, May 13, 2024, amid concerns about rising prices ahead of inflation data due later in the ...
Additional information regarding the NanoViricides Platform Technology, and the NanoViricides Drug Pipeline can be found in ...
News updates from May 10: US says Israel’s use of its arms may have violated humanitarian law; Jim Simons dies on facebook (opens in a new window) News updates from May 10: US says Israel’s use of its ...
Thunder fans across the state are getting ready for game four of the Western Conference Semi-Finals. The Thunder team is back ...